Roberto Iacone
Amministratore Delegato presso Alentis Therapeutics AG
Profilo
Roberto Iacone is the founder of Bright Peak Therapeutics AG, Ridgeline Therapeutics.
He is currently the Chief Executive Officer & Director at Alentis Therapeutics AG and a Venture Partner at Pureos Partners AG.
Dr. Iacone holds a doctorate degree from Università degli Studi di Napoli Federico II.
Posizioni attive di Roberto Iacone
| Società | Posizione | Inizio |
|---|---|---|
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Amministratore Delegato | 29/07/2020 |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investitore di Private Equity | - |
Precedenti posizioni note di Roberto Iacone
| Società | Posizione | Fine |
|---|---|---|
| Ridgeline Therapeutics | Fondatore | - |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Head-Fixed Income Invts | - |
Formazione di Roberto Iacone
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
| Ridgeline Therapeutics | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Finance |
- Borsa valori
- Insiders
- Roberto Iacone
